As of 2026-07-02, the Relative Valuation of Cardiff Oncology Inc (CRDF) is (8.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.30 USD, the upside of Cardiff Oncology Inc based on Relative Valuation is -728.5%.
The range of the Relative Valuation is (7.62) - (8.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 17.0x | 15.9x |
| Forward P/E multiples | 12.8x - 18.9x | 15.8x |
| Fair Price | (7.62) - (8.75) | (8.17) |
| Upside | -686.0% - -773.1% | -728.5% |
| Date | P/E |
| 2026-06-29 | -2.50 |
| 2026-06-26 | -2.43 |
| 2026-06-25 | -2.35 |
| 2026-06-24 | -2.45 |
| 2026-06-23 | -2.43 |
| 2026-06-22 | -2.53 |
| 2026-06-18 | -2.35 |
| 2026-06-17 | -2.29 |
| 2026-06-16 | -2.45 |
| 2026-06-15 | -2.76 |
| 2026-06-12 | -2.99 |
| 2026-06-11 | -3.09 |
| 2026-06-10 | -2.88 |
| 2026-06-09 | -2.97 |
| 2026-06-08 | -2.91 |
| 2026-06-05 | -2.91 |
| 2026-06-04 | -3.01 |
| 2026-06-03 | -2.72 |
| 2026-06-02 | -2.93 |
| 2026-06-01 | -2.88 |
| 2026-05-29 | -3.69 |
| 2026-05-28 | -3.57 |
| 2026-05-27 | -3.52 |
| 2026-05-26 | -3.77 |
| 2026-05-22 | -3.46 |
| 2026-05-21 | -3.48 |
| 2026-05-20 | -3.57 |
| 2026-05-19 | -3.42 |
| 2026-05-18 | -3.28 |
| 2026-05-15 | -3.24 |
| 2026-05-14 | -3.36 |
| 2026-05-13 | -3.28 |
| 2026-05-12 | -3.19 |
| 2026-05-11 | -3.17 |
| 2026-05-08 | -3.19 |
| 2026-05-07 | -3.11 |
| 2026-05-06 | -3.26 |
| 2026-05-05 | -3.13 |
| 2026-05-04 | -3.21 |
| 2026-05-01 | -3.32 |
| 2026-04-30 | -3.36 |
| 2026-04-29 | -3.15 |
| 2026-04-28 | -3.26 |
| 2026-04-27 | -3.34 |
| 2026-04-24 | -3.34 |
| 2026-04-23 | -3.24 |
| 2026-04-22 | -3.36 |
| 2026-04-21 | -3.21 |
| 2026-04-20 | -3.46 |
| 2026-04-17 | -3.50 |